Latest news
Fit to fund: UK biotech VC investment surges to five-year high - BioXconomyBioXconomy · Fri, 07 Aug 2026 10:51:38 GMTAI underused in trial conduct says ACRO - BioXconomyBioXconomy · Thu, 06 Aug 2026 08:31:19 GMTNeurologic trial tools inadequate researchers say - BioXconomyBioXconomy · Tue, 04 Aug 2026 20:38:56 GMTFDA committee approves loosening peptide regulation despite own evidence - BioXconomyBioXconomy · Tue, 04 Aug 2026 16:35:58 GMTAstraZeneca reportedly eyeing $400bn merger with BMS - BioXconomyBioXconomy · Mon, 03 Aug 2026 11:08:19 GMT